Menu
Recruiting NCT07337278

Posturography Rehabilitation and Pelvic Floor Training on Urinary Incontinence in Women

No phase Interventional Urinary Incontinence

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pelvic Floor Muscle Training, Posturography Rehabilitation.
Who it may be relevant to
Registry conditions: Urinary Incontinence. Basic parameters: 18 years — 65 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Morocco
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effect of Lumbopelvic Rehabilitation Using Posturography Combined With Pelvic Floor Training on Urinary Incontinence in Women

Overview

The goal of this clinical trial is to evaluate whether lumbopelvic postural rehabilitation combined with pelvic floor muscle training (PFMT) is more effective than PFMT alone in women with urinary incontinence. The main questions it aims to answer are: * Does the addition of lumbopelvic postural rehabilitation improve the severity of urinary incontinence as measured by the ICIQ-UI-SF questionnaire? * Does it improve urinary symptom profile, pelvic floor muscle strength, patient-reported overall improvement, and quality of life compared to PFMT alone? Participants will be randomly assigned to one of two groups: * Experimental group (Group A): PFMT (3 sessions/week) plus lumbopelvic postural rehabilitation (2 sessions/week) for 12 weeks. * Control group (Group B): PFMT alone (3 sessions/week) for 12 weeks. Participants will perform pelvic floor exercises in supine and seated positions, with supervised sessions at the hospital and home exercises. Postural rehabilitation includes stability and mobility exercises for the lumbopelvic region using Posturography. Outcomes will be assessed at baseline, at 6 weeks, and at 12 weeks.

Interventions

  • Behavioral Pelvic Floor Muscle Training
    Pelvic floor training consists of voluntary contractions of the pelvic floor muscles, using short, rapid contractions combined with slow, sustained contractions, aimed at improving strength and endurance. Training is performed in supine and seated positions, with one supervised session per week at the hospital and three home sessions per week, over a total duration of 12 weeks.
  • Behavioral Posturography Rehabilitation
    Postural rehabilitation consists of seated exercises focusing on stability and mobility of the lumbopelvic region, using posturography. Sessions last 30 minutes, conducted twice weekly, over a total duration of 12 weeks.

Primary outcome measures

  • International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF) [Time frame: 6 weeks and 12 weeks from start of intervention]
Secondary outcome measures (4)
  • Patient Global Impression of Improvement (PGI-I) [Time frame: 6 weeks and 12 weeks from start of intervention]
  • Urinary Symptom Profile (USP) scores [Time frame: 6 weeks and 12 weeks from start of intervention]
  • Pelvic Floor Muscle Strength (Modified Oxford Scale) [Time frame: 6 weeks and 12 weeks from start of intervention]
  • Incontinence Impact Questionnaire - Short Form (IIQ-7) [Time frame: 6 weeks and 12 weeks from start of intervention]

Eligibility criteria

Inclusion criteria

  • Female participants aged between 18 and 65 years
  • Presence of clinical signs of urinary incontinence (stress urinary incontinence and/or urge urinary incontinence and/or mixed urinary incontinence) diagnosed according to the International Continence Society (ICS) terminology
  • USP (urinary symptom profile) scores for stress urinary incontinence and/or overactive bladder ≥ 1
  • Normal neuro-perineal examination
  • Written informed consent provided prior to participation in the study

Exclusion criteria

  • Known detrusor overactivity or reduced bladder compliance of neurological origin
  • Associated voiding dysfunction, defined as a Urinary Symptom Profile (USP) dysuria subscale score ≥ 1
  • Known organic or morphological pathology of the lower urinary tract
  • Pelvic organ prolapse grade II or higher according to the Pelvic Organ Prolapse Quantification system (POP-Q)
  • Current urinary tract infection or vaginal infection
  • Cognitive or visual impairments that may interfere with understanding or performing the exercise program
  • Pregnant women or women within 10 months postpartum
  • Anticholinergic medication use or hormone replacement therapy within the last 6 months
  • Recent pelvic or abdominal surgery within the last 6 months

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Morocco · 1 center
  • Al Ayachi Hospital, CHU Ibn Sina — Rabat

Identifiers

NCT: NCT07337278 · UM5-MPR-2025-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗